Amy Raymond, PhD, Director of Therapeutic Expertise, Center for Rare Diseases
Amy brings a comprehensive understanding of drug discovery and drug development from the research laboratory to the patient through 20+ years of experience in academic institutions, pharmaceutical companies, and CROs. Originally trained as a molecular biologist, she is grateful to leverage her experience to improve human health through innovation. She provides full life cycle support—from study design and data quality considerations through completing enrollment and study close out—for trials serving rare disease patient communities.
More from Amy
Spotlight on Amy Raymond: Bulldog and Deep-Diving Thinker
Healthcare intelligence (HQ) is what we call PRA’s unique mixture of intellectual expertise, empathy for the patient experience, and passion for…
The RACE for Children Act: How Industry Can Accelerate Readiness Through Collaboration With Patient Organizations
This whitepaper offers a high-level orientation around the key barriers to readiness and critical success factors for companies navigating the…